Non Proliferative Diabetic Retinopathy
7
0
0
1
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
28.6%
2 terminated out of 7 trials
33.3%
-53.2% vs benchmark
57%
4 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Changes in Macular Thickness After Patterns Scan Laser
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR
Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy
Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study
Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures
Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy